Ayca Iribas Celik

5PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Mar 10, 2025
Impact of extended [177Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?

Edanur Topal, Bilal Kovan, Ayca İribas

|Jul 27, 2022
Efficacy of the VIT (vincristine, irinotecan and temozolomide) regimen in adults with metastatic Ewing sarcoma.

Izzet Dogan, Ayca Iribas, Melin Aydan Ahmed

|Sep 22, 2021
Effects of different molecular subtypes and tumor biology on the prognosis of medulloblastoma.

Yavuz Aras, Duygu Dölen, Ayca İribas Çelik

Pageof 1